These results evidenced that the Zn//MnO2 battery could improve the tumor immunogenicity by releasing DAMPs after the ICD effect, activating the cGAS-STING pathway, promoting DC maturation, and reversing the immunosuppressive microenvironment. The gene discussed is STING1; the disease is neoplasm.